These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 20116757

  • 1. [Impact of efficacy and mortality studies (TORCH and UPLIFT) in bronchodilator treatment of chronic obstructive pulmonary disease].
    Soler-Cataluña JJ, García MA.
    Arch Bronconeumol; 2009; 45 Suppl 5():14-20. PubMed ID: 20116757
    [Abstract] [Full Text] [Related]

  • 2. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?
    Niewoehner DE.
    COPD; 2009 Feb; 6(1):1-3. PubMed ID: 19229702
    [Abstract] [Full Text] [Related]

  • 3. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 4. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
    Tashkin DP.
    Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
    [Abstract] [Full Text] [Related]

  • 5. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 6. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM, Bollmeier SG, Finnegan PM.
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [Abstract] [Full Text] [Related]

  • 7. Mega trials in COPD--clinical data analysis and design issues.
    Suissa S, Ernst P.
    Pneumonol Alergol Pol; 2011 Dec; 79(3):227-31. PubMed ID: 21509736
    [Abstract] [Full Text] [Related]

  • 8. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
    Anzueto A.
    Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
    [Abstract] [Full Text] [Related]

  • 9. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
    Tashkin DP.
    Curr Opin Pulm Med; 2010 Mar; 16(2):97-105. PubMed ID: 20019615
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of tiotropium in the prevention of exacerbations of COPD.
    Anzueto A, Miravitlles M.
    Ther Adv Respir Dis; 2009 Jun; 3(3):103-11. PubMed ID: 19617284
    [Abstract] [Full Text] [Related]

  • 11. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, TORCH investigators.
    N Engl J Med; 2007 Feb 22; 356(8):775-89. PubMed ID: 17314337
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL, Baker EL, Coleman CI.
    Pharmacotherapy; 2009 Aug 22; 29(8):891-905. PubMed ID: 19637942
    [Abstract] [Full Text] [Related]

  • 13. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA, Donohue JF.
    Semin Respir Crit Care Med; 2010 Jun 22; 31(3):321-33. PubMed ID: 20496301
    [Abstract] [Full Text] [Related]

  • 14. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.
    Postgrad Med; 2010 Sep 22; 122(5):150-64. PubMed ID: 20861599
    [Abstract] [Full Text] [Related]

  • 15. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).
    Morice AH, Celli B, Kesten S, Lystig T, Tashkin D, Decramer M.
    Respir Med; 2010 Nov 22; 104(11):1659-67. PubMed ID: 20724131
    [Abstract] [Full Text] [Related]

  • 16. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, UPLIFT Study Investigators.
    N Engl J Med; 2008 Oct 09; 359(15):1543-54. PubMed ID: 18836213
    [Abstract] [Full Text] [Related]

  • 17. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E, Lazarus SC.
    J Allergy Clin Immunol; 2009 Nov 09; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [Abstract] [Full Text] [Related]

  • 18. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
    Koumis T, Samuel S.
    Clin Ther; 2005 Apr 09; 27(4):377-92. PubMed ID: 15922812
    [Abstract] [Full Text] [Related]

  • 19. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM, Beier J.
    Adv Ther; 2010 Mar 09; 27(3):150-9. PubMed ID: 20411368
    [Abstract] [Full Text] [Related]

  • 20. Pharmacotherapy for mortality reduction in chronic obstructive pulmonary disease.
    Sin DD, Man SF.
    Proc Am Thorac Soc; 2006 Sep 09; 3(7):624-9. PubMed ID: 16963545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.